AMGEN AND GENERATE BIOMEDICINES ANNOUNCE MULTI-TARGET, MULTI-MODALITY RESEARCH COLLABORATION AGREEMENTPRNewsWire • 01/06/22
Amgen downgraded at COVID-19, pricing headwinds could push out growth inflection to next yearMarket Watch • 01/05/22
AMGEN TO PRESENT AT THE GOLDMAN SACHS 14TH ANNUAL HEALTHCARE CEOS UNSCRIPTED CONFERENCEPRNewsWire • 12/23/21
FDA APPROVES OTEZLA® (APREMILAST) FOR THE TREATMENT OF ADULT PATIENTS WITH PLAQUE PSORIASIS, REGARDLESS OF SEVERITY LEVELPRNewsWire • 12/20/21
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ DebutBenzinga • 12/20/21